Status:
NOT_YET_RECRUITING
Glucose Levels in Acute Pancreatitis and the Impact of Insulin Depletion and Bacterial Endotoxaemia
Lead Sponsor:
Manchester University NHS Foundation Trust
Conditions:
Pancreatitis, Acute
Hyperglycaemia
Eligibility:
All Genders
18+ years
Brief Summary
There are currently no early predictive biomarkers for severity of acute pancreatitis (AP) that would allow stratification of patients for potential early interventional therapies. Hyperglycaemia is f...
Detailed Description
Acute pancreatitis (AP) is associated with metabolic dysregulation including dysglycaemia which may predict poor clinical outcomes. Continuous glucose monitoring (CGM) offers a novel method for assess...
Eligibility Criteria
Inclusion
- Age 18 years or over
- Admission diagnosis of acute pancreatitis (based on Revised Atlanta Criteria)
- Ability to provide informed consent in English
Exclusion
- Known diabetes mellitus
- Use of insulin therapy before admission
- Pregnancy
- Contraindications to CGM (e.g., allergy to device adhesive)
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06972238
Start Date
December 1 2025
End Date
August 30 2026
Last Update
May 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.